Art

J-GLOBAL ID：201202278581615901   Reference number：12A0031773

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

未治療の急性骨髄性白血病を有する成人患者における標準用量イダルビシンと高用量ダウノルビシンの併用と比較した導入療法に関する無作為化試験:JALSG AML201試験

Author (21)： OHTAKE Shigeki (Kanazawa Univ. Graduate School of Medical Sci., Kanazawa, JPN) ,  MIYAWAKI Shuichi (Saiseikai Maebashi Hospital, Maebashi, JPN) ,  FUJITA Hiroyuki (Yokohama City Univ. Graduate School of Medicine, Yokohama, JPN) ,  KIYOI Hitoshi (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  SHINAGAWA Katsuji (Okayama Univ. Hospital, Okayama, JPN) ,  USUI Noriko (Jikei Univ. School of Medicine, Tokyo, JPN) ,  OKUMURA Hirokazu (Kanazawa Univ. Graduate School of Medical Sci., Kanazawa, JPN) ,  MIYAMURA Koichi (Japanese Red Cross Nagoya First Hospital, Nagoya, JPN) ,  NAKASEKO Chiaki (Chiba Univ. Hospital, Chiba, JPN) ,  MIYAZAKI Yasushi (Nagasaki Univ. Graduate School of Biomedical Sci., Nagasaki, JPN) ,  FUJIEDA Atsushi (Mie Univ. Graduate School of Medicine, Tsu, JPN) ,  NAGAI Tadashi (Jichi Medical Univ., Shimotsuke, JPN) ,  YAMANE Takahisa (Osaka City Univ., Osaka, JPN) ,  TANIWAKI Masafumi (Kyoto Prefectural Univ. Of Medicine, Kyoto, JPN) ,  TAKAHASHI Masatomo (St Marianna Univ. School of Medicine, Kawasaki, JPN) ,  YAGASAKI Fumiharu (Saitama Medical School, Hidaka, JPN) ,  KIMURA Yukihiko (Tokyo Medical Univ., Tokyo, JPN) ,  ASOU Norio (Kumamoto Univ. School of Medicine, Kumamoto, JPN) ,  SAKAMAKI Hisashi (Tokyo Metropolitan Komagome Hospital, Tokyo, JPN) ,  HANDA Hiroshi (Gunma Univ. Graduate School of Medicine, Maebashi, JPN) ,  NAOE Tomoki (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN)
Material： Blood
Volume： 117  Issue： 8  Page： 2358-2365  Publication year： Feb. 24, 2011 
JST Material Number： H0084A  ISSN： 0006-4971  CODEN： BLOOA  Document type： Article
Country of issue： United States (USA)  Language： ENGLISH (EN)

Terms in the title (14)： 治療 ,  急性骨髄性白血病 ,  成人 ,  患者 ,  標準 ,  用量 ,  イダルビシン ,  高用量 ,  ダウノルビシン ,  併用 ,  療法 ,  無作為化試験 ,  JALSG ,  試験